32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine

) Interest Coverage 269.3 29.2 Debt Service Coverage 222.7 5.0 Total Debt to Equity 0.2 0.5 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of

61.01 Total Debt to Equity 0.18 0.16 * calculated by using earning four previous consecutive quarters ** based on only cost of medicine & medical supplies

% which was an increase in lease liability from accounting measure No. 16. While the shareholders' equity is 1,305.1 million baht. This gives the company a total debt to equity ratio of 1.38 times and

Structure At the end of the year 2016, the Company recorded total debt to equity ratio of 17.8 times. The interest bearing debt to equity ratio was 13.1 times. As of June 30th, 2017, total debt to equity

, the Company recorded total debt to equity ratio of 17.8 times. The interest bearing debt to equity ratio was 13.1 times. As of June 30th, 2017, total debt to equity ratio was reduced greatly at 5.4

Shares of the Company under the Debt to Equity Conversion Scheme, ACO I will become a majority shareholder of the Company with a shareholding of 76.09 percent of the total issued shares of the Company

Ordinary Shares of the Company under the Debt to Equity Conversion Scheme must be approved by the shareholders’ meeting of the Company with votes of not less than three-fourths of the total votes of the

the Company under the Debt to Equity Conversion Scheme must be approved by the shareholders’ meeting of the Company with votes of not less than three-fourths of the total votes of the shareholders

(26%) Operating Cash Flow5 405 385 276 47% 1,301 955 36% Net Debt to Equity (times) 0.92 0.94 0.71 29% 0.92 0.87 6% *The total amount of IRSL was excluded from Core Financials 2Q19, but was consolidated